Frequently asked Questions about Stem Cell Therapy
About stem cell therapy
What is stem cell therapy?
Stem cell therapy is a form of regenerative medicine in which stem cells - or their derivatives such as exosomes - are administered to promote tissue repair, reduce inflammation, and support the body's natural healing processes. It is not a single treatment but a broad category of protocols varying by cell type, source, dose, and delivery route.
What conditions can stem cell therapy address?
Research and clinical experience support applications across a range of neurological, autoimmune, and degenerative conditions. At Medical Cells Network we advise primarily on: Parkinson's disease, multiple sclerosis, Alzheimer's disease, autism spectrum disorder, cerebral palsy, ALS, type 2 diabetes, Crohn's disease, and healthy ageing. Each has a distinct evidence base - see our individual condition pages for details.
Is stem cell therapy a cure?
For the conditions we advise on, current evidence most strongly supports slowing of disease progression, reduction of inflammation, and functional improvements - not complete cure. We believe in setting realistic, evidence-based expectations. Any provider claiming a guaranteed cure should be treated with serious scepticism.
Safety and Quality
Is stem cell therapy safe?
When conducted with GMP-certified cells at regulated clinical facilities, the safety profile of MSC and allogeneic pluripotent therapies is well established across multiple clinical trials. Serious adverse events are rare. The key variables are cell source quality, production standards, and the clinical environment. We only advise on protocols meeting all three criteria.
What is GMP certification and why does it matter?
Good Manufacturing Practice (GMP) certification means that the cells were produced under pharmaceutical-grade conditions: controlled sterility, documented donor screening, batch traceability, and viability standards. Non-GMP cells carry infection risks and unpredictable potency. It is non-negotiable for any serious therapeutic application.
What are the risks of going to an unregulated clinic?
Unregulated providers - many operating in countries with minimal medical oversight - may offer non-GMP cells, undisclosed cell types, inadequate patient screening, and no follow-up protocols. Documented cases of serious adverse events have occurred in these settings. One of the primary purposes of Medical Cells Network is to help patients identify and avoid these providers.
The treatment process
What happens during a consultation with Medical Cells Network?
Your consultation begins with a detailed intake process: we review your medical history, current diagnosis, previous and current treatments, and goals. Based on this, we identify the protocols in the published literature most relevant to your profile and present them to you clearly. If a protocol is appropriate, we match you with a vetted, GMP-certified clinical partner.
Where are treatments administered?
Depending on your condition and the most appropriate protocol, treatments are available in Germany, Switzerland, and Georgia (Tbilisi). All partner clinics operate under national health authority oversight and use GMP-Standard cell preparations.
How many treatment sessions are needed?
This varies by condition and protocol. Most programmes involve an initial series of 2-4 administrations over several weeks, followed by a monitoring period. Many patients elect a repeat course after 12-18 months. We will discuss the specific schedule applicable to your case during consultation.
Do I need to travel to Germany, Switzerland or Gerogia?
The initial consultation takes place via video call - wherever you are in the world. Travel to the treatment site is required for the actual therapy. We assist with logistics coordination through our clinical partners.
Costs and Practicalities
How much does stem cell therapy cost?
Treatment costs vary significantly depending on the condition, cell type, number of sessions, and clinical partner. Detailed cost information is provided as part of the advisory process, once a suitable protocol has been identified. We do not provide generic cost estimates, as they are protocol-specific.
Is stem cell therapy covered by health insurance?
In most European jurisdictions, investigational stem cell therapies are not covered by statutory health insurance. Some private insurance policies include coverage for experimental procedures - we recommend reviewing your policy in advance and we can provide supporting documentation where needed.
Is stem cell therapy legal?
Yes - but the regulatory framework matters enormously. The rules differ depending on the type of therapy:
Autologous therapies (using the patient's own cells) have a more accessible regulatory pathway in Germany and Switzerland. Certain autologous cell preparations fall outside full ATMP classification under the "hospital exemption" or "same surgical procedure" exemption, meaning they can be administered in licensed clinical settings in both countries under specific conditions.
Allogeneic therapies (using donor-derived cells) are classified as Advanced Therapy Medicinal Products (ATMPs) in Germany and Switzerland and require full marketing authorisation to be administered - making routine clinical access extremely limited in both countries.
For this reason, our allogeneic treatment programmes are carried out at a licensed clinical partner hospital in Tbilisi, Georgia, which operates under a well-established regulatory framework specifically permitting allogeneic cell therapies under hospital-based conditions. Georgia is a recognised medical travel destination with EU-aligned GMP manufacturing standards.
Medical Cells Network provides advisory and coordination services. All allogeneic treatment is administered exclusively at regulated, licensed facilities under German medical protocols.
About Medical Cells Network
Who is Medical Cells Network?
Medical Cells Network is an independent medical advisory service specialising in stem cell and exosome therapies. We do not operate a clinic and do not administer treatments directly. Our role is to provide patients and families with rigorous, science-based guidance through the complex and often confusing landscape of regenerative medicine. Our advisors have over 12 years of experience and have supported over 1,100 patients through advisory processes across Europe and internationally.
How is your advisory service different from going directly to a clinic?
A clinic has an inherent commercial interest in providing treatment. We are independent advisors - our only interest is in identifying whether a treatment is genuinely appropriate for you, and if so, which protocol and provider offers the best scientific match for your profile. We have no preferred-provider commercial arrangements.
How do I get started?
Book a free video consultation using the form below. We will respond within 24 hours to schedule your initial call.